The potential role of α‐synuclein as disease modifying therapies in Parkinson’s disease

Activity: Lecture / Presentation › Oral presentation › Academic

Description

Part I: The physiological role of α‐synuclein
Part II: α‐Synuclein‐mediated pathogenesis of PD
Period3 Apr 2020
Event titleAdvances in Alzheimer's and Parkinson's therapies: An AAT-AD/PD Focus meeting
Event typeConference
Degree of RecognitionInternational

Keywords

  • Parkinson's disease
  • disease mechanisms
  • alpha-synuclein